Medication Therapy Management to Optimize Care Through Effective Resource Management in Inflammatory Bowel Disease

Overview

About this study

The management of Inflammatory Bowel Disease (IBD) is complex and time consuming. While Current Procedural Terminology for MTM services are available they are under-utilized given the time constraints placed on practitioners trying to address multiple health care issues during a single visit. There are companies that specialize in patient pharmacy services to improve health care outcomes. Our aim is to utilize these services in a small number of IBD patients to assess effectiveness of such services within a tertiary care practice.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inlcusion Criteria:

  • Adult patients
  • Naïve to a biologic
  • Being switched from another agent or being re-introduced after an extended time period (no longer than 12 months)

Exclusion Criteria:

  • Prescriptions that are refills
  • Patients with need for urgent hospitalization
  • Pregnant patients 
  • Those without a reliable and confirmed shipping address or reliable telephone access
  • Residing outside of the United States

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Rochester, Minn.

Mayo Clinic principal investigator

Sunanda Kane, M.D.

Closed for enrollment

Scottsdale/Phoenix, Ariz.

Mayo Clinic principal investigator

Shabana Pasha, M.D.

Closed for enrollment

Jacksonville, Fla.

Mayo Clinic principal investigator

Michael Picco, M.D., Ph.D.

Closed for enrollment

Eau Claire, Wis.

Mayo Clinic principal investigator

Sunanda Kane, M.D.

Closed for enrollment

Mankato, Minn.

Mayo Clinic principal investigator

Shilun Li, M.D.

Closed for enrollment

La Crosse, Wis.

Mayo Clinic principal investigator

Michael Van Norstrand, M.D., Ph.D.

Closed for enrollment

More information

Publications

Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available

.
CLS-20359592

Mayo Clinic Footer